• Syed Wajid Clinical Pharmacy Department, Drug and Poison Information Center, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
  • Mohamed N Al-arifi Drug and Poison Information Center, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia



Objectives: The purpose of this study was to design a suitable transdermal therapeutic system for venlafaxine hydrochloride (VFH) with the objective
to prolong the release to be used for controlled release drug delivery.
Methods: Transdermal patches of VFH with a hydroxypropyl methylcellulose drug reservoir were prepared by the solvent evaporation technique.
In this investigation, the Eudragit RSPO membrane in different concentrations was cast to achieve controlled release of the drug. The absence of
physiochemical interactions between VFH and the polymers was confirmed by Fourier transform infrared spectroscopy. The physicochemical
parameters and in-vitro drug release studies of formulations were performed and data of optimized formulation were fitted to various kinetic models.
Results: The results indicated that suitable tri-layered transdermal patches of VFH with controlled drug release could be prepared. All the formulations
exhibited satisfactory physicochemical characteristics. Among the formulations prepared, formulation F2 showed optimized controlled release for
24 hrs (96.42%) with the flux of 28.28 μg/cm2/hr and permeability coefficient of 1.1315×10−3 cm/hr. Drug release from optimized patch followed
Korsmeyer-Peppas model and was mediated by Fickian diffusion mechanism.
Conclusion: Hence, the development of adhesive type tri-layered transdermal patches for VFH might be a promising one to control the drug release
for 24 hrs with reduced side-effects.

Keywords: Venlafaxine hydrochloride, Tri-layered transdermal patch, Plasticizer, In-vitro drug release study, In-vitro permeation study.


Download data is not yet available.


Vyas SP, Khar RK. Controlled Drug Delivery Concepts and Advances. New Delhi: Vallabh Prakashan; 2002.

Arti K, Kumar YA, Sunil S, Gautam H, Haribansh NS, Anamika S, et al. Theoretical aspects of transdermal drug delivery system. Bull Pharm Res 2013;3(2):78-89.

British Pharmacopoeia. Vol. 2. United Kingdom: The Stationery Office; 2008. p. 2242.

Available from: [Last accessed on 2013 Feb 13].

Madhavi BB, Nath AR, David B, Ramalingam R, Madhu MN, Arjun G, et al. Formulation and evaluation of venlafaxine HCL enclosed in alginate microbeads prepared by iontophoretic gellation method. Int J Pharm Res Dev 2009;8:1-11.

Sweetman SC. Martindale: The Complete Drug Reference. London: Pharmaceutical Press; 2009.

Available from: [Last accessed on 2013 Mar 21].

Gajanan D, Kumar JD, Kumar PV. Formulation and evaluation of transdermal drug delivery system of clopidogrel bisulfate. Asian J Pharm Life Sci 2011;1(3):269-78.

Suchika S, Geeta A, Sanju D. Design and evaluation of Olanzapine transdermal patches containing vegetable oils as permeation enhancers. Der Pharm Lettre 2010;2(6):84-98.

Naseera K, Sajeeth CI, Santhi K. Formulation, optimization and evaluation of matrix type of transdermal system of simvastatin using permeation enhancers. Int J Curr Pharm Res 2012;4(2):79-87.

Kumar MP, Prasad MR, Pramod M, Reddy VP. Effect of permeation enhancer on ex-vivo permeation of ondansetron HCL buccal tablets. Int J Pharm Sci Res 2011;2(11):2841-5.

Prajapati ST, Patel CG, Patel CN. Formulation and evaluation of transdermal patch of repaglinide. ISRN Pharm 2011;2011:651909.

Madishetti SK, Palem CR, Gannu R, Thatipamula RP, Panakanti PK, Yamsani MR. Development of domperidone bilayered matrix type transdermal patches: Physicochemical, in vitro and ex vivo characterization. Daru 2010;18:221-9.

Tanwar YS, Chauhan CS, Sharma A. Development and evaluation of carvedilol transdermal patches. Acta Pharm 2007;57(2):151-9.

Shivaraj A, Selvam RP, Mani TT, Sivakumar T. Design and evaluation of transdermal drug delivery of Ketotifen fumarate. Int J Pharm Biomed Res 2010;1(2):42-7.

Alka V, Bhupesh V, Sunil P, Kishu T. Formulation and evaluation of transdermal therapeutic system of matrix type clonidine hydrochloride. Der Pharm Lettre 2012;4(4):1137-42.

Amish AD, Zankhana PS, Janki J. Formulation and evaluation of transdermal ondansetron hydrochloride matrix patch: In-vitro skin permeation and irritation study. Int J Pharm Res Allied Sci 2012;2:26‑34.

Teja AR, Hemant KS, Swetha S, Prasad MS. Preparation and evaluation of transdermal patches of metformin hydrochloride using natural polymer for sustained release. Int J Pharm Pharm Sci 2012;4(3):297‑302.

Vidyavati S, Jithan A. Development and evaluation of zero order sustained release matrix type transdermal films of ibuprofen. J Glob Pharma Technol 2010;2(2):51-8.

Ubaidulla U, Reddy MV, Ruckmani K, Ahmad FJ, Khar RK. Transdermal therapeutic system of carvedilol: Effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech 2007;8:2.

Dhawal D. Formulation and In-vitro evaluation of transdermal patches of methyl salicylate. Int J Pharm Technol 2012;4(2):4208-17.

Madhura SD, Sheelpriya RW, Abhay MI. Development and characterization of transdermal patches of ondansetron hydrochloride Int J Pharm Pharm Sci 2012;4(5):293-8.

Kumar KJ, Muralidharan S, Dhanaraj SA. Formulation and in vitro evaluation of terbinafine HCL transdermal patches. J Pharm Sci Res 2012;4(6):1840-3.

Kulkarni VH, Keshavayya J, Shastry CS, Preeti V, Kulkarni. Transdermal delivery of antiasthmatic drug through modified chitosan membrane. Indian J Pharm Sci 2005;67(5):544-7.

Muzib YI, Lavanya T. Design and evaluation of stavudine transdermal patches using hydrophilic and hydrophobic polymers. J Pharm Res 2012;5(2):1176-82.

Prasad Verma PR, Chandak AR. Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance. Acta Pharm 2009;59:171-86.

Vishnu YV, Kishan V, Rao YM. Enhanced bioavailability of nimodipine from bioadhesive buccal bilayered patches in human volunteers. Br J Pharm Res 2013;3(4):1015-30.

Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 2010;67:217-23.

Yogesh MA, Rupesh VC, Updesh BL, Dinesh MB, Milind JU. Design, formulation and evaluation of transdermal drug delivery system of budesonide. Dig J Nanomater Biostruct 2011;6(2):475-97.30. Saumya D, Dharmajit P, Prasad SN. Optimization and evaluation of terbutaline sulphate transdermal film. Int J Pharm Technol 2011;3(4):3612-7.

Anisree GS, Ramasamy C, John C, Wesley I. Design and evaluation of domperidone transdermal films. J Pharm Res 2012;5(8):3942-4.

Mitali G. Formulation and evaluation of transdermal patch of an antihypertensive drug. Pharma Sci Monit 2013;4(1):3664-82.

Kunal NP, Hetal KP, Vishnu AP. Formulation and characterization of drug in adhesive transdermal patches of diclofenac acid. Int J Pharm Pharm Sci 2012;4(1):296-9.

Amit KV, Om PM, Nimisha Dipti S. Formulation and evaluation of transdermal patch containing turmeric oil. Int J Pharm Pharm Sci 2012;4(5):358-61.

Eva Snejdrova and Milan Dittrich .Pharmaceutical Application of plasticized polymers in : Recent Advances in Plasticizers. Edited by Mohammad Luqman. Published by In TECH 2012; 69-90.



How to Cite

Safoora Afreen, V. V. Y, S. S. Al saleh, Syed Wajid, SHIVA KUMAR R, M. N. Al-arifi, and SUHA S ALSALEH. “DESIGN AND IN-VITRO EVALUATION OF CONTROLLED RELEASE TRI-LAYER VENLAFAXINE HCL TRANSDERMAL PATCH”. Asian Journal of Pharmaceutical and Clinical Research, vol. 8, no. 3, May 2015, pp. 271-7,



Original Article(s)